CAR T-cell Therapies for the Treatment of Patients with Acute Lymphoblastic Leukemia

Acute Lymphoblastic Leukemia (AML), also called acute myeloblastic leukemia, acute myelogenous leukemia, acute myeloid leukemia, or acute nonlymphocytic leukemia, is an aggressive, fast-growing, heterogenous group of blood cancers that arise as a result of clonal expansion of myeloid hematopoietic precursors in the bone marrow. Not only are circulating leukemia […]

View Original Source at CAR T-cell Therapies for the Treatment of Patients with Acute Lymphoblastic Leukemia